BLU-554

• Description:

  BLU-554 (Fisogatinib, BLU554) is a novel potent, highly selective and orally bioavailable inhibitor of FGFR4 designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  503.3777

• Molecular Formula:

  C24H24Cl2N4O4

• Notes:

  Research use only, not for human use.

• Receptor:

  FGFR1|FGFR2|FGFR3|FGFR4

• CAS Number:

  1707289-21-1